Nanocarriers as an emerging platform for cancer therapy D Peer, JM Karp, S Hong, OC Farokhzad, R Margalit, R Langer Nano-enabled medical applications, 61-91, 2020 | 9543 | 2020 |
Cancer nanomedicine: progress, challenges and opportunities J Shi, PW Kantoff, R Wooster, OC Farokhzad Nature reviews cancer 17 (1), 20-37, 2017 | 4936 | 2017 |
Factors affecting the clearance and biodistribution of polymeric nanoparticles F Alexis, E Pridgen, LK Molnar, OC Farokhzad Molecular pharmaceutics 5 (4), 505-515, 2008 | 4148 | 2008 |
Impact of nanotechnology on drug delivery OC Farokhzad, R Langer ACS nano 3 (1), 16-20, 2009 | 3713 | 2009 |
Nanoparticles in medicine: therapeutic applications and developments L Zhang, FX Gu, JM Chan, AZ Wang, RS Langer, OC Farokhzad Clinical pharmacology & therapeutics 83 (5), 761-769, 2008 | 3154 | 2008 |
Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology N Bertrand, J Wu, X Xu, N Kamaly, OC Farokhzad Advanced drug delivery reviews 66, 2-25, 2014 | 2981 | 2014 |
Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release N Kamaly, B Yameen, J Wu, OC Farokhzad Chemical reviews 116 (4), 2602-2663, 2016 | 2535 | 2016 |
Cellular uptake of nanoparticles: journey inside the cell S Behzadi, V Serpooshan, W Tao, MA Hamaly, MY Alkawareek, ... Chemical society reviews 46 (14), 4218-4244, 2017 | 2216 | 2017 |
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo OC Farokhzad, J Cheng, BA Teply, I Sherifi, S Jon, PW Kantoff, JP Richie, ... Proceedings of the National Academy of Sciences 103 (16), 6315-6320, 2006 | 2176 | 2006 |
Nanotechnology in drug delivery and tissue engineering: from discovery to applications J Shi, AR Votruba, OC Farokhzad, R Langer Nano letters 10 (9), 3223-3230, 2010 | 1868 | 2010 |
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation N Kamaly, Z Xiao, PM Valencia, AF Radovic-Moreno, OC Farokhzad Chemical Society Reviews 41 (7), 2971-3010, 2012 | 1842 | 2012 |
Nanoparticle delivery of cancer drugs AZ Wang, R Langer, OC Farokhzad Annual review of medicine 63 (1), 185-198, 2012 | 1799 | 2012 |
Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug delivery J Cheng, BA Teply, I Sherifi, J Sung, G Luther, FX Gu, ... Biomaterials 28 (5), 869-876, 2007 | 1640 | 2007 |
Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology U Prabhakar, H Maeda, RK Jain, EM Sevick-Muraca, W Zamboni, ... Cancer research 73 (8), 2412-2417, 2013 | 1576 | 2013 |
Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells OC Farokhzad, S Jon, A Khademhosseini, TNT Tran, DA LaVan, ... Cancer research 64 (21), 7668-7672, 2004 | 1220 | 2004 |
Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile J Hrkach, D Von Hoff, MM Ali, E Andrianova, J Auer, T Campbell, ... Science translational medicine 4 (128), 128ra39-128ra39, 2012 | 1207 | 2012 |
Quantum dot− aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer V Bagalkot, L Zhang, E Levy-Nissenbaum, S Jon, PW Kantoff, R Langer, ... Nano letters 7 (10), 3065-3070, 2007 | 1207 | 2007 |
Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt (IV) prodrug-PLGA–PEG nanoparticles S Dhar, FX Gu, R Langer, OC Farokhzad, SJ Lippard Proceedings of the National Academy of Sciences 105 (45), 17356-17361, 2008 | 1189 | 2008 |
Self-assembled lipid− polymer hybrid nanoparticles: a robust drug delivery platform L Zhang, JM Chan, FX Gu, JW Rhee, AZ Wang, AF Radovic-Moreno, ... ACS nano 2 (8), 1696-1702, 2008 | 1064 | 2008 |
Nanomedicine: developing smarter therapeutic and diagnostic modalities OC Farokhzad, R Langer Advanced drug delivery reviews 58 (14), 1456-1459, 2006 | 1009 | 2006 |